Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ágnes Dobi"'
Autor:
Bence Nagy-Mikó, Orsolya Németh-Szatmári, Réka Faragó-Mészáros, Aliz Csókási, Bence Bognár, Nóra Ördög, Barbara N. Borsos, Hajnalka Majoros, Zsuzsanna Ujfaludi, Orsolya Oláh-Németh, Aliz Nikolényi, Ágnes Dobi, Renáta Kószó, Dóra Sántha, György Lázár, Zsolt Simonka, Attila Paszt, Katalin Ormándi, Tibor Pankotai, Imre M. Boros, Zoltán Villányi, András Vörös
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 21, p 15869 (2023)
We aimed to investigate the contribution of co-translational protein aggregation to the chemotherapy resistance of tumor cells. Increased co-translational protein aggregation reflects altered translation regulation that may have the potential to buff
Externí odkaz:
https://doaj.org/article/8d99ae6f8b0c4be19e261e922f262a5a
Autor:
Katalin Priskin, Sára Pólya, Lajos Pintér, Gábor Jaksa, Bernadett Csányi, Márton Zsolt Enyedi, Eszter Sági-Zsigmond, Farkas Sükösd, Orsolya Oláh-Németh, Gyöngyi Kelemen, Alíz Nikolényi, Gabriella Uhercsák, Dóra Sántha, Ágnes Dobi, Éva Szilágyi, Erzsébet Valicsek, László Tordai, Rozália Tóth, Zsuzsanna Kahán, Lajos Haracska
Publikováno v:
Cancers, Vol 13, Iss 14, p 3489 (2021)
Circulating tumor DNA (ctDNA) is increasingly employed in the screening, follow-up, and monitoring of the continuously evolving tumor; however, most ctDNA assays validated for clinical use cannot maintain the right balance between sensitivity, covera
Externí odkaz:
https://doaj.org/article/22ec5a79d67449369ff0378bcb87d5e9
Autor:
Bence Nagy-Mikó, Orsolya Németh-Szatmári, Réka Faragó-Mészáros, Aliz Csókási, Bence Bognár, Nóra Ördög, Barbara N. Borsos, Hajnalka Majoros, Zsuzsanna Ujfaludi, Orsolya Oláh-Németh, Aliz Nikolényi, Ágnes Dobi, Renáta Kószó, Dóra Sántha, György Lázár, Zsolt Simonka, Attila Paszt, Katalin Ormándi, Tibor Pankotai, Imre M. Boros, Zoltán Villányi, András Vörös
We aimed to investigate the contribution of co-translational protein aggregation to the chemotherapy resistance of tumor cells. Increased co-translational protein aggregation reflects altered translation regulation that may have the potential to buff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58b565ea54e71304666d0a63b023cc12
https://doi.org/10.1101/2023.01.13.523908
https://doi.org/10.1101/2023.01.13.523908
Autor:
Barbara Darázs, Lehel Ferenczi, Zoltán Varga, Viktor Paczona, Katalin Hideghéty, Ágnes Dobi, Laszlo Rusko, Zoltán Végváry, Emese Fodor
Publikováno v:
Physica Medica. 68:35-40
The aim of this retrospective study was to investigate the relationship between the dose to the subventricular zone (SVZ) and overall survival (OS) of 41 patients with glioblastoma multiforme (GBM), who were treated with an adaptive approach involvin
Autor:
Katalin Hideghéty, Dávid Kis, Adrienn Cserháti, Pál Barzó, Zoltán Végváry, Barbara Darázs, Judit Oláh, Zita Reisz, Emese Fodor, Zoltán Varga, Ágnes Dobi, Viktor Paczona
Publikováno v:
Anticancer research. 40(8)
To study the changes of glioblastoma multiforme during chemoradiotherapy (CRT) and to evaluate the impact of changes on dosimetry and clinical outcomes.Forty-three patients underwent volumetric imaging-based replanning. Prognostic factors and gross t
Autor:
Barbara Darázs, Szilvia László, Emese Fodor, Ágnes Dobi, Zita Reisz, Leopold Dodd, Adrienne Cserháti, Judit Oláh, Anikó Maráz, Pál Barzó, Zsófia Együd, Katalin Hideghéty
Publikováno v:
Pathology Oncology Research
The aim of the present study was to evaluate the efficacy of re-irradiation (re-RT) in patients with advanced local relapses of glial tumours and to define the factors influencing the result of the hyper-fractionated external beam therapy on progress
Autor:
Katalin Hideghéty, Zsófia Együd, Pál Barzó, László Tiszlavicz, Emese Fodor, Zita Reisz, Adrienne Cserháti, Anikó Maráz, Zoltán Varga, Ágnes Dobi
Publikováno v:
Pathology & Oncology Research. 26:149-157
Our retrospective analysis aimed to evaluate the clinical value of dose intensification schemes: WBRT and consecutive, delayed, or simultaneous integrated boost (SIB) in brain metastasis (BM) management. Clinical data and overall survival (OS) of 468
Autor:
Márton Zsolt Enyedi, Orsolya Oláh-Németh, Bernadett Csányi, Farkas Sükösd, Alíz Nikolényi, Gyöngyi Kelemen, Zsuzsanna Kahán, László Tordai, Lajos Haracska, Sára Pólya, Ágnes Dobi, Éva Szilágyi, Dóra Sántha, Eszter Sági-Zsigmond, Erzsébet Valicsek, Katalin Priskin, Rozália Tóth, Gábor Jaksa, Lajos Pintér, Gabriella Uhercsák
Publikováno v:
Cancers
Volume 13
Issue 14
Cancers, Vol 13, Iss 3489, p 3489 (2021)
Volume 13
Issue 14
Cancers, Vol 13, Iss 3489, p 3489 (2021)
Circulating tumor DNA (ctDNA) is increasingly employed in the screening, follow-up, and monitoring of the continuously evolving tumor
however, most ctDNA assays validated for clinical use cannot maintain the right balance between sensitivity, co
however, most ctDNA assays validated for clinical use cannot maintain the right balance between sensitivity, co
Autor:
Gabriella Uhercsák, Ágnes Dobi, Adrienne Cserháti, Alíz Nikolényi, Melinda Csenki, Orsolya Rusz, Renáta Kószó, Erzsébet Valicsek, Zsuzsanna Kahán
Publikováno v:
OncoTargets and therapy. 11
Orsolya Rusz, Renáta Kószó, Ágnes Dobi, Melinda Csenki, Erzsébet Valicsek, Alíz Nikolényi, Gabriella Uhercsák, Adrienne Cserháti, Zsuzsanna Kahán Department of Oncotherapy, University of Szeged, Szeged, Hungary Abstract: Fulvestrant is a pu